Bowman Birk inhibitor concentrate and oral leukoplakia: A randomized phase IIb trial.

Trial Profile

Bowman Birk inhibitor concentrate and oral leukoplakia: A randomized phase IIb trial.

Completed
Phase of Trial: Phase II

Latest Information Update: 12 Mar 2013

At a glance

  • Drugs Bowman-Birk inhibitor concentrate (Primary)
  • Indications Orofacial cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 06 Mar 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
    • 23 Oct 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top